Here’s a bold claim: a simple vaccine might not only shield you from a painful condition but also slow down the aging process itself. But here’s where it gets controversial—could something as routine as a shingles vaccine hold the key to healthier, longer-lived cells? New research from the USC Leonard Davis School of Gerontology suggests exactly that, revealing that the shingles vaccine may do far more than prevent a rash. It could be linked to slower biological aging in older adults, a finding that challenges how we think about vaccines and their broader health benefits.
Scientists dove into data from the U.S. Health and Retirement Study, analyzing over 3,800 adults aged 70 and older in 2016. After accounting for health and demographic differences, they found that vaccinated individuals showed slower biological aging compared to their unvaccinated peers. And this is the part most people miss—it’s not just about avoiding shingles; it’s about potentially slowing down the body’s aging clock.
What Exactly Is Shingles, and Why Should You Care?
Shingles, or herpes zoster, is a painful rash caused by the reactivation of the varicella zoster virus, the same one responsible for chickenpox. While anyone who’s had chickenpox is at risk, the chances of developing shingles skyrocket after age 50, especially in those with weakened immune systems. Vaccination not only reduces the risk of shingles but also lowers the likelihood of postherpetic neuralgia, a lingering nerve pain that can persist long after the rash fades.
The Surprising Link Between Vaccines and Aging
Vaccines are typically seen as infection fighters, but emerging research hints at their broader health benefits. Jung Ki Kim, the study’s lead author and Research Associate Professor of Gerontology, points out that previous studies have tied adult vaccines—like those for shingles and influenza—to lower risks of dementia and other neurodegenerative diseases. This study adds another layer, suggesting vaccines might modulate biological systems in ways that promote healthy aging.
Biological Aging vs. Chronological Age: What’s the Difference?
Biological aging measures how well your body’s systems are functioning, not just how many birthdays you’ve celebrated. Two 65-year-olds can have vastly different biological profiles—one might have organs and systems resembling those of a younger person, while the other shows signs of accelerated aging. To explore this, Kim and coauthor Eileen Crimmins evaluated seven markers of biological aging, including inflammation, immune function, cardiovascular health, and genetic changes. They then combined these into an overall biological aging score.
The Role of Inflammation in Aging
One of the most striking findings? Vaccinated participants had lower inflammation levels, slower cellular aging, and better overall biological aging scores. Chronic, low-grade inflammation—often called “inflammaging”—is a key driver of age-related conditions like heart disease, frailty, and cognitive decline. By reducing this background inflammation, possibly by preventing the reactivation of the shingles virus, the vaccine may support healthier aging. But here’s a thought-provoking question—could this mean vaccines are an untapped tool in the fight against age-related decline?
Long-Lasting Benefits
The study also found that the benefits of vaccination persisted over time. Participants vaccinated four or more years before the study still showed slower biological aging compared to unvaccinated individuals. This suggests the vaccine’s effects aren’t just short-lived but could influence aging for years.
What Does This Mean for You?
While more research is needed, especially longitudinal studies, these findings add to a growing body of evidence that vaccines might play a role in healthy aging strategies. As Crimmins notes, it’s not just about preventing illness but potentially slowing age-related decline. So, here’s a question for you—if vaccines could indeed slow aging, would that change how you view their importance? Let us know in the comments!
About the Study
Published in the Journals of Gerontology, Series A: Biological Sciences and Medical Sciences on January 20, 2026, the study, titled “Association between shingles vaccination and slower biological aging: Evidence from a U.S. population-based cohort study,” was supported by the National Institute on Aging at the National Institutes of Health (P30 AG017265). The Health and Retirement Study is funded by the National Institute on Aging (U01AG009740).
